Aspirin for Heart Risk Winnipeg MB

Taking aspirin reduces heart attack risk in people with no previous history of vascular disease but increases the risk of internal bleeding, say British researchers who analyzed the results of 22 clinical trials. This means the net effect in this group of patients is uncertain because the benefits and risks may cancel each other out. However, the researchers found that aspirin's benefits generally outweigh its risks among people who have vascular disease in Winnipeg.

Milambiling-Perez Medical Associates
(204) 956-5963
233 Kennedy St
Winnipeg, MB
 
Mowchun Leon Dr
(204) 787-3200
771 Bannatyne Ave
Winnipeg, MB
 
Ip Angel Dr Phys
(204) 783-6464
878 Ellice Ave
Winnipeg, MB
 
Nor'west Co-Op Community Health Centre Inc
(204) 940-2020
Winnipeg, MB
 
Cumming G R Dr Physician
(204) 957-3335
Winnipeg Clinic
Winnipeg, MB
 
Manitoba Clinic
(204) 788-5511
Winnipeg, MB
 
Jensen C Dr Urologist
(204) 957-3306
Winnipeg Clinic
Winnipeg, MB
 
Osler Barker Brodovsky Gall & Chan Drs
(204) 943-0629
233 Kennedy St
Winnipeg, MB
 
Winnipeg Clinic
(204) 957-3252
Winnipeg, MB
 
Medical Arts Building Limited
(204) 284-4938
Winnipeg, MB
 

Aspirin for Heart Risk

Provided By:

FRIDAY, May 29 (HealthDay News) --Taking aspirin reduces heart attack risk in people with no previous history of vascular disease but increases the risk of internal bleeding, say British researchers who analyzed the results of 22 clinical trials.

This means the net effect in this group of patients is uncertain because the benefits and risks may cancel each other out. However, the researchers found that aspirin's benefits generally outweigh its risks among people who have vascular disease.

Colin Baigent, of the University of Oxford, and colleagues looked at serious vascular events (heart attack, stroke or vascular death) among 95,000 low-risk patients in six primary prevention trials and among 17,000 high-risk patients in 16 secondary prevention trials.

Among patients in the primary prevention trials, aspirin was found to reduce the risk of serious vascular events by 12 percent but increased the risk of internal bleeding by about one-third. Among patients in the secondary prevention studies -- who were already at high risk because they had previously experienced a stroke or heart attack -- aspirin reduced the risk of serious vascular events by about one-fifth, a benefit that outweighed the small additional risk of bleeding, the researchers said.

The results in both sets of trials were similar for men and women.

"The currently available trial results do not seem to justify general guidelines advocating the routine use of aspirin in all healthy individuals above a moderate level of risk for coronary heart disease," the study authors wrote in the May 30 issue of The Lancet.

"Drug safety really matters when making recommendations for tens of millions of healthy people," Baigent said in a news release. "We don't have good evidence that, for healthy people, the benefits of long-term aspirin exceed the risks by an appropriate margin. If effectiveness is uncertain, then cost-effectiveness calculations are irrelevant."

More information

The American Heart Association has more about the role of aspirin in heart attack and stroke prevention.

SOURCE: The Lancet, news release, May 28, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com